R.A. (Rudolf) de Boer

Rudolf de Boer (1972, Gouda, the Netherlands) is a Clinical Cardiologist, a Full Professor of Translational Cardiology, and the Director of the Experimental Cardiology at the University Medical Center Groningen, the Netherlands (https://www.groningencardiology.com).  He studied medicine at the University of Groningen, completed research fellowships at the University of Utah, the University of Groningen, and at Harvard Medical School.

 His research group focuses on cardiac remodeling and heart failure, fibrosis, diabetes, and cardio-oncology, always trying to connect clinical observations to preclinical and mechanistic studies. The last years he has studied biomarkers in clinical heart failure and in the general population, and focused on their role in the pathophysiology. Recently he focused on the interaction of heart failure and co-morbidities, especially cancer. He has been was a founding member the scientific committee of LifeLines, a population study of 165,000 subjects. Doctor de Boer’s clinical interests are cardiogenetics, echocardiography and end-stage heart failure including VAD therapy and transplant.  

Dr. de Boer has authored and co-authored over 400 articles in peer reviewed journals (https://www.ncbi.nlm.nih.gov/pubmed/?term=de+boer+ra) and wrote over 10 book chapters. He received grants from grants from the Netherlands Heart Foundation and the Dutch Organization for Scientific Research (VENI 2009, VIDI 2013) and an ERC consolidator grant in 2019. I was a member the scientific committee of LifeLines (www.lifelines.net), and was appointed a Fellow of the European Society of Cardiology (ESC) in 2010. I furthermore have been the president of the Heart Failure Working Group of the Dutch Society of Cardiology (2013-2019), and in 2014 I was elected as board member of the Heart Failure Association of the ESC. I have been member of the ESC Advocacy, Education and eHealth Committees. Currently, I am President-elect of the Dutch Society of Cardiology (NVVC), and Liaison Officer of the ESC council on Cardio-oncology.  

I have been an Associate Editor of the European Journal of Heart Failure from 2009-2019, and am associate editor of the European Heart Journal (section Heart Failure),  as well as being reviewer for several other journals, including JAMA, Circulation, the Journal of the American College of Cardiology, and several more Journals.